Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 4Triple Negative Breast Neoplasms 3Breast Neoplasms 2Recurrence 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cancer Recurrent 1Neoplasm Metastasis 1Melanoma 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 27Cisplatin 17Oxaliplatin 16Cytoreduction Surgical Procedures 15Paclitaxel 12Fluorouracil 10Mitomycin 8Leucovorin 8Doxorubicin 7Docetaxel 5Neoadjuvant Therapy 4Blood Specimen Collection 4Taxes 3Surgical Procedures, Operative 3Chemotherapy, Adjuvant 3Carboplatin 3Bevacizumab 3catumaxomab 2Platinum 2Palliative Care 2Observation 2Nivolumab 2Mitozytrex 2Laparoscopy 2Interviews as Topic 2Indocyanine Green 2Folfox protocol 2Albumin-Bound Paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Peritoneal Neoplasms × poly(I).poly(c12,U) × Clear all
NCT02151448 2020-07-20

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

University of Pittsburgh

Phase 1/2 Completed
64 enrolled 18 charts
Gynecologic

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡